Related Experiment Video
Updated: Jun 5, 2026

09:12
Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
Published on: March 17, 2019
Impulse control disorders and punding in Parkinson's disease: the need for a structured interview
1Unidad de Neurología, Hospital General de l'Hospitalet, Consorci Sanitari Integral, L'Hospitalet de Llobregat, Barcelona, Spain. asuncion.avila@sanitatintegral.org
Neurologia (Barcelona, Spain)
|December 18, 2010
Summary
Impulse control disorders and punding are common in Parkinson's disease (PD) but often go unrecognized. A screening questionnaire is crucial for detecting these underreported symptoms in PD patients.
Area of Science:
- Neurology
- Psychiatry
Background:
- Impulse control disorders (ICD) and punding are frequently observed in Parkinson's disease (PD) patients.
- These behaviors, including hypersexuality and compulsive gambling, are often underreported by patients and thus under-recognized in clinical practice.
Purpose of the Study:
- To assess the prevalence of ICD and punding in Parkinson's disease patients.
- To highlight the under-recognition of these conditions in routine clinical settings.
Main Methods:
- Prospective screening of 216 idiopathic PD patients using a questionnaire on ICD and punding symptoms.
- Retrospective analysis of 216 age- and sex-matched idiopathic PD patients who spontaneously reported symptoms.
Main Results:
- Only 9.26% of prospective PD patients reported ICD or punding, with specific conditions like hypersexuality (3.24%) and punding (3.70%) noted.
- In the retrospective group, only 2.31% spontaneously reported symptoms, indicating significant underreporting.
Conclusions:
- Parkinson's disease patients frequently do not spontaneously disclose ICD or punding symptoms.
- A dedicated screening questionnaire is essential for the accurate detection and management of these under-recognized behaviors in PD.
Related Concept Videos
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

